-transparent.png){kind=logo}
Pirenzepine and carbenozolone in gastric ulcer. Preliminary results of a multicentre double-blind controlled clinical trial. 1979
L Barbara, and
E Belsasso, and
A Blasi, and
E Caenazzo, and
G Di Febo, and
F Di Mario, and
M Giorgi-Conciato, and
F Marletta, and
M Miglioli, and
M Petrillo, and
M Salvagnini, and
G Scalabrin
Pirenzepine (PRZ) 75 mg/day for 1 week followed by 50 mg/day for 3 weeks did not show a good activity in gastric ulcer healing in comparison to carbenoxolone (CB) (300 mg/day for 1 week followed by 200 mg/day for 3 weeks). The tolerability of PRZ seemed to be better than that of CB. The increase in the daily dose of PRZ to 100 mg/day for 4 weeks led to better results in the patients who have completed satisfactorily the treatment up to now. PRZ's tolerability was greater than CB's. The results of this study are preliminary to further trial.
Related Publications
L Barbara, and
E Belsasso, and
A Blasi, and
E Caenazzo, and
G Di Febo, and
F Di Mario, and
M Giorgi-Conciato, and
F Marletta, and
M Miglioli, and
M Petrillo, and
M Salvagnini, and
G Scalabrin
January 1990,
The Journal of international medical research,
L Barbara, and
E Belsasso, and
A Blasi, and
E Caenazzo, and
G Di Febo, and
F Di Mario, and
M Giorgi-Conciato, and
F Marletta, and
M Miglioli, and
M Petrillo, and
M Salvagnini, and
G Scalabrin
January 1979,
Scandinavian journal of gastroenterology. Supplement,
L Barbara, and
E Belsasso, and
A Blasi, and
E Caenazzo, and
G Di Febo, and
F Di Mario, and
M Giorgi-Conciato, and
F Marletta, and
M Miglioli, and
M Petrillo, and
M Salvagnini, and
G Scalabrin
January 1979,
Scandinavian journal of gastroenterology. Supplement,
L Barbara, and
E Belsasso, and
A Blasi, and
E Caenazzo, and
G Di Febo, and
F Di Mario, and
M Giorgi-Conciato, and
F Marletta, and
M Miglioli, and
M Petrillo, and
M Salvagnini, and
G Scalabrin
January 1982,
Scandinavian journal of gastroenterology. Supplement,
L Barbara, and
E Belsasso, and
A Blasi, and
E Caenazzo, and
G Di Febo, and
F Di Mario, and
M Giorgi-Conciato, and
F Marletta, and
M Miglioli, and
M Petrillo, and
M Salvagnini, and
G Scalabrin
January 1982,
Digestion,
L Barbara, and
E Belsasso, and
A Blasi, and
E Caenazzo, and
G Di Febo, and
F Di Mario, and
M Giorgi-Conciato, and
F Marletta, and
M Miglioli, and
M Petrillo, and
M Salvagnini, and
G Scalabrin
January 1979,
Scandinavian journal of gastroenterology. Supplement,
L Barbara, and
E Belsasso, and
A Blasi, and
E Caenazzo, and
G Di Febo, and
F Di Mario, and
M Giorgi-Conciato, and
F Marletta, and
M Miglioli, and
M Petrillo, and
M Salvagnini, and
G Scalabrin
January 1983,
International journal of tissue reactions,
L Barbara, and
E Belsasso, and
A Blasi, and
E Caenazzo, and
G Di Febo, and
F Di Mario, and
M Giorgi-Conciato, and
F Marletta, and
M Miglioli, and
M Petrillo, and
M Salvagnini, and
G Scalabrin
December 1988,
Lancet (London, England),
L Barbara, and
E Belsasso, and
A Blasi, and
E Caenazzo, and
G Di Febo, and
F Di Mario, and
M Giorgi-Conciato, and
F Marletta, and
M Miglioli, and
M Petrillo, and
M Salvagnini, and
G Scalabrin
January 1982,
Scandinavian journal of gastroenterology. Supplement,
L Barbara, and
E Belsasso, and
A Blasi, and
E Caenazzo, and
G Di Febo, and
F Di Mario, and
M Giorgi-Conciato, and
F Marletta, and
M Miglioli, and
M Petrillo, and
M Salvagnini, and
G Scalabrin
July 1979,
The Medical journal of Australia,
